BioWorld

Oct. 4, 2005

View Archived Issues

Metabasis Advancing Internal Programs With $41M Funding

As it prepares to bring two more of its internally discovered products into the clinic, Metabasis Therapeutics Inc. raised $41.3 million in a private placement of common stock and warrants. (BioWorld Today) Read More

HGS Awarded Government Contract For Anthrax Drug

Read More

Genetic Privacy Act Gains Energy; Gingrich Weighs In

Read More

Lilly, GlycoFi Sign Agreement To Enhance Drugs With Sugars

Read More

Other News To Note

Read More

U.S. Patent Disclosures

Read More